Cargando…

Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder

Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Joseph, Lin, Shih-Ku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054796/
https://www.ncbi.nlm.nih.gov/pubmed/32148990
http://dx.doi.org/10.1155/2020/2615748

Ejemplares similares